Large-cap Health Care company Humana has logged a -7.7% change today on a trading volume of 3,861,027. The average volume for the stock is 1,245,193.
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. Based in Louisville, United States the company has 65,000 full time employees and a market cap of $35,182,665,728. Humana currently offers its equity investors a dividend that yields 1.1% per year.
The company is now trading -25.46% away from its average analyst target price of $392.01 per share. The 21 analysts following the stock have set target prices ranging from $349.0 to $439.0, and on average give Humana a rating of buy.
Over the last 12 months HUM shares have declined by -35.2%, which represents a difference of -71.4% when compared to the S&P 500. The stock's 52 week high is $530.54 per share and its 52 week low is $286.67. With its net margins declining an average -4.1% over the last 6 years, Humana declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 106,374,000 | 2,489,000 | 2 | -33.33 |
| 2022 | 92,870,000 | 2,806,000 | 3 | -25.0 |
| 2021 | 83,064,000 | 2,933,000 | 4 | 0.0 |
| 2020 | 77,155,000 | 3,367,000 | 4 | 0.0 |
| 2019 | 64,888,000 | 2,707,000 | 4 | 33.33 |
| 2018 | 56,912,000 | 1,683,000 | 3 |
